Vifor Pharma has had a presence in Singapore since 2003, with a diverse portfolio including products for the following areas:

The iron franchise focuses its activities on the treatment and prevention of iron deficiency, with or without anaemia, the most common and widespread nutritional disorder in the world. Key brands in the iron replacement product portfolio are Ferinject®, Venofer® and Maltofer®.
The Infectious Diseases / OTX product portfolio includes products for the improvement of cognitive function and development, chronic obstructive pulmonary disease, respiratory tract Infections, lower urinary tract infections, microvascular circulation problems and hemostatics.

As the regional hub for Asia Pacific the Singapore office manages the collaboration with its partners responsible for the marketing and distribution of its products in 17 countries.